EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Therapeutic potential of targeting macrophages and microglia in glioblastoma

Fei Zhou, Pritha Mukherjee, Jinming Mu, Peiwen Chen

Trends in Pharmacological Sciences · 2025

DOI: 10.1016/j.tips.2025.07.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2025. Verfasst von Fei Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Glioblastoma, Microglia, Brain Neoplasms, Macrophages. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, U.S. Department of Defense, Cancer Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is a highly aggressive and lethal form of brain tumor in human adults that resists standard of care (SOC) and immunotherapy. Tumor-associated macrophages and microglia (TAMs) represent the most abundant cell population within the GBM tumor microenvironment (TME), comprising up to 50% of the whole tumor mass. TAMs play a pivotal role in promoting tumor progression, driving immunosuppression and inducing therapy resistance. Recent advances have revealed TAM heterogeneity - including their cellular identity (e.g., bone marrow-derived macrophages versus microglia) and the presence of distinct activation/function states and subpopulations within each subtype - in GBM tumors. Targeting the context-dependent TAM infiltration, reprogramming, new subpopulations, survival, phagocytosis, and their interactions with GBM cells in the TME has emerged as a promising therapeutic strategy. Herein we review recent advances in pharmacological targeting of the TAM biology and highlight how these strategies may enhance the effectiveness of SOC and immunotherapies in GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMicrogliaBrain NeoplasmsMacrophagesTumor-Associated MacrophagesHumansAnimalsTumor MicroenvironmentImmunotherapy

Stichwörter der Autor:innen

glioblastomaimmunotherapytumor microenvironment (TME)tumor-associated macrophages and microglia (TAMs)

Autor:innen und Institutionen

  • Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: CHENP6@ccf.org.

Förderung

  • NINDS NIH HHS
  • U.S. Department of Defense
  • Cancer Research Institute
  • NIH

Zitieren

APA

Zhou, F., Mukherjee, P., Mu, J., & Chen, P. (2025). Therapeutic potential of targeting macrophages and microglia in glioblastoma. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2025.07.006

Vancouver

Zhou F, Mukherjee P, Mu J, Chen P. Therapeutic potential of targeting macrophages and microglia in glioblastoma. Trends in Pharmacological Sciences. 2025. doi:10.1016/j.tips.2025.07.006

BibTeX
@article{Zhou2025,
  author = {Zhou, Fei and Mukherjee, Pritha and Mu, Jinming and Chen, Peiwen},
  title = {Therapeutic potential of targeting macrophages and microglia in glioblastoma},
  journal = {Trends in Pharmacological Sciences},
  year = {2025},
  doi = {10.1016/j.tips.2025.07.006}
}
Kostenlos starten →